Business / Finance

RSS

Amedica launches innovative articulating inserter for minimally invasive TLIF procedures

Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce the release of its Scorpion™ articulating inserter to accompany the Valeo II™ TL interbody fusion device system. The Scorpion inserter will be commercially available mid-November 2015, and will aide in minimally-invasive transforaminal lumbar interbody fusion surgeries.

15 Oct 2015

Commonwealth Lab expands access to new IBS test with national agreement with Quest

Commonwealth Laboratories, LLC ("Commonwealth") announced today that it has formed an agreement with Quest Diagnostics ("Quest") that will expand the availability of IBSchek™, a new laboratory developed blood test designed to help physicians quickly and reliably diagnose Irritable Bowel Syndrome (IBS).

From Quest Diagnostics 15 Oct 2015

TxCell reviews its manufacturing strategy to focus on R&D and strategic partnerships - its core, high added value businesses

TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it is operating a strategic review that should result in the outsourcing of all existing and future clinical and commercial manufacturing operations to contract manufacturing organizations (CMOs).

15 Oct 2015

Merck unveils new global brand as a science and technology company

Merck, a leading science and technology company, today announced the relaunch of its brand identity. The fundamental revision of the visual appearance as well as the introduction of a new logo reflect the transformation into a global science and technology company. At the same time, the brand architecture at business level has been simplified. Outside the United States and Canada, the company will operate uniformly as Merck.

15 Oct 2015

Chemical Heritage Foundation announces merger with Life Sciences Foundation

On October 9, 2015, the board of directors of the Chemical Heritage Foundation (CHF) in Philadelphia approved a merger with the Life Sciences Foundation (LSF) of San Francisco. On October 11, the Life Sciences Foundation board approved the same plan.

15 Oct 2015

Intuitive Surgical and Trumpf Medical team up to address hospitals’ need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical’s advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

15 Oct 2015

OncoSec reports net loss of $6.5 million for fourth quarter of fiscal 2015

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the fourth quarter and fiscal year ended July 31, 2015.

15 Oct 2015

Rene Lenggenhager is announced Biospin group president

Bruker today announces the appointment of Dr. Rene Lenggenhager as President of the Bruker BioSpin Group, effective November 1st, 2015

14 Oct 2015

enGene, Janssen Biotech sign agreement to develop and commercialize new IBD therapies

enGene, Inc. a gene therapy company focused on development of therapeutics using its proprietary "Gene Pill" and enema gene delivery platform, today announced that it has entered into a definitive agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop and commercialize new therapies for inflammatory bowel disease (IBD).

14 Oct 2015

Phagelux announces purchase of Scithera Microbial Technologies' key assets

Phagelux, Inc., a leading anti-bacterial company, is pleased to announce the purchase of the key assets of Scithera Microbial Technologies, Ltd., headquartered in Wuhan China, a pioneer in the research and development of lysin solutions for pathogen control in the field of human health.

14 Oct 2015

XTL signs agreement with Yeda to amend development milestones for lupus treatment

XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of unmet clinical needs with a focus on treatments for autoimmune diseases, today announced that it has reached agreement with Yeda Research and Development Company Ltd. to amend the development milestones in the License Agreement signed between the parties in January 2014 for the development of hCDR1 for the treatment of systemic lupus erythematosus (SLE).

13 Oct 2015

Gensignia gets CLIA certification to establish clinical laboratory in San Diego

Gensignia Life Sciences, Inc. (Gensignia) announced today that it received certification under the Clinical Laboratory Improvement Amendments (CLIA).

13 Oct 2015

MiMedx posts record revenue of $49M in Q3 2014

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, announced today its record revenue results for the third quarter of 2015, its guidance for the fourth quarter of 2015, and that the Company has secured a $50 million Senior Secured Credit Facility.

13 Oct 2015

Nobel Laureate Harold Varmus, MD to delivery anniversary discourse at The New York Academy of Medicine November 5

Harold Varmus, MD, co-recipient of the 1989 Nobel Prize in Medicine and Lewis Thomas University Professor of Medicine at Meyer Cancer Center of Weill Cornell Medical College, will deliver the 168th Anniversary Discourse at The New York Academy of Medicine. The event will take place on Thursday, November 5, 2015 at 6:00 p.m. at the Academy (1216 Fifth Avenue at 103rd Street) and is free and open to the public with registration.

13 Oct 2015

Astute Medical, Fosun Long-March sign distribution agreement for NephroCheck Test on the Astute140 Meter

Astute Medical, Inc. today announced the signing of an agreement with Shanghai Fosun Long March Medicine Science Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd., for distribution of Astute's NephroCheck Test on the Astute140 Meter in China. In addition to its planned launch of the NephroCheck Test in China, FOSUNPHARMA invested $20 million in Astute.

12 Oct 2015

MiNDERA closes $1 million Seed financing round

MiNDERA Corp., a leader in non-invasive molecular diagnostics for dermatology and skin-related cancers, announced today the close of its $1 million Seed financing round. Scientific Health Development and other individual investors are among MiNDERA's new investors. This financing round will enable MINDERA to further validate its proprietary micro-needle technology and prepare for the launch of its first research products.

12 Oct 2015

Lilly acquires worldwide rights to intranasal glucagon from Locemia

Eli Lilly and Company and Locemia Solutions today announced Lilly has acquired worldwide rights to Locemia's intranasal glucagon, a potential treatment for severe hypoglycemia in people with diabetes treated with insulin. Intranasal glucagon, which is currently in Phase III clinical trial testing, could be the first needle-free rescue treatment for severe hypoglycemia.

11 Oct 2015

Roche to acquire biotechnology company, Adheron Therapeutics

Adheron Therapeutics, a privately held biotechnology company based in Berkeley, California, United States, announced today that it has agreed to be acquired by Roche.

9 Oct 2015

Hi-Tech Pharmaceuticals signs definitive agreement to acquire iForce

Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition products, Contract Manufacturing, and iForce Nutrition ("iForce"), one of the fastest-growing Sports Nutrition companies in the United States, today announced that they have entered into a definitive agreement in which Hi-Tech has agreed to acquire iForce.

9 Oct 2015

Immunovia and OHSU team up to validate, commercialize blood test for early diagnosis of pancreatic cancer

Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer. The test called IMMray™ PanCan-d analyses a patient's immune system for early signs of disease. The collaboration will also enable researchers to explore biomarkers for a number of other cancer types.

9 Oct 2015

Business / Finance

Amedica launches innovative articulating inserter for minimally invasive TLIF procedures

Commonwealth Lab expands access to new IBS test with national agreement with Quest

TxCell reviews its manufacturing strategy to focus on R&D and strategic partnerships - its core, high added value businesses

Merck unveils new global brand as a science and technology company

Chemical Heritage Foundation announces merger with Life Sciences Foundation

Intuitive Surgical and Trumpf Medical team up to address hospitals’ need for operating room integration

OncoSec reports net loss of $6.5 million for fourth quarter of fiscal 2015

Rene Lenggenhager is announced Biospin group president

enGene, Janssen Biotech sign agreement to develop and commercialize new IBD therapies

Phagelux announces purchase of Scithera Microbial Technologies' key assets

XTL signs agreement with Yeda to amend development milestones for lupus treatment

Gensignia gets CLIA certification to establish clinical laboratory in San Diego

MiMedx posts record revenue of $49M in Q3 2014

Nobel Laureate Harold Varmus, MD to delivery anniversary discourse at The New York Academy of Medicine November 5

Astute Medical, Fosun Long-March sign distribution agreement for NephroCheck Test on the Astute140 Meter

MiNDERA closes $1 million Seed financing round

Lilly acquires worldwide rights to intranasal glucagon from Locemia

Roche to acquire biotechnology company, Adheron Therapeutics

Hi-Tech Pharmaceuticals signs definitive agreement to acquire iForce

Immunovia and OHSU team up to validate, commercialize blood test for early diagnosis of pancreatic cancer

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News